Concepts (246)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microglia | 24 | 2024 | 166 | 6.160 |
Why?
|
| Chemokine CX3CL1 | 9 | 2024 | 13 | 3.160 |
Why?
|
| Receptors, Chemokine | 16 | 2016 | 70 | 2.890 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2023 | 94 | 2.090 |
Why?
|
| Retina | 7 | 2024 | 280 | 2.050 |
Why?
|
| Inflammation | 9 | 2024 | 618 | 1.800 |
Why?
|
| Mice | 37 | 2024 | 5913 | 1.490 |
Why?
|
| Mice, Transgenic | 13 | 2024 | 617 | 1.470 |
Why?
|
| Central Nervous System | 8 | 2016 | 135 | 1.290 |
Why?
|
| Neurocysticercosis | 5 | 2016 | 30 | 1.250 |
Why?
|
| Chemokines | 5 | 2016 | 97 | 1.190 |
Why?
|
| Animals | 44 | 2024 | 15081 | 1.190 |
Why?
|
| Gliosis | 2 | 2024 | 24 | 1.120 |
Why?
|
| Disease Models, Animal | 12 | 2024 | 1371 | 1.120 |
Why?
|
| Diabetic Retinopathy | 2 | 2024 | 68 | 1.090 |
Why?
|
| Myeloid Cells | 4 | 2013 | 29 | 1.040 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 4 | 2016 | 54 | 0.990 |
Why?
|
| Brain | 10 | 2016 | 1346 | 0.960 |
Why?
|
| Demyelinating Diseases | 2 | 2022 | 15 | 0.960 |
Why?
|
| Mice, Inbred C57BL | 19 | 2023 | 1609 | 0.880 |
Why?
|
| Ancrod | 1 | 2022 | 2 | 0.830 |
Why?
|
| Diabetes Mellitus | 2 | 2024 | 485 | 0.800 |
Why?
|
| Cell Separation | 3 | 2014 | 93 | 0.750 |
Why?
|
| Chemotaxis | 2 | 2013 | 60 | 0.740 |
Why?
|
| Interleukin-1beta | 2 | 2017 | 70 | 0.700 |
Why?
|
| Fibrinogen | 4 | 2023 | 23 | 0.690 |
Why?
|
| Flow Cytometry | 8 | 2015 | 399 | 0.660 |
Why?
|
| Leukocytes | 3 | 2018 | 72 | 0.650 |
Why?
|
| Astrocytes | 2 | 2024 | 255 | 0.640 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 3 | 2003 | 16 | 0.610 |
Why?
|
| Central Nervous System Diseases | 2 | 2017 | 29 | 0.600 |
Why?
|
| Cytokines | 9 | 2024 | 602 | 0.560 |
Why?
|
| Eosinophilia | 1 | 2016 | 18 | 0.560 |
Why?
|
| Leukocytes, Mononuclear | 5 | 2015 | 234 | 0.520 |
Why?
|
| Receptors, CCR2 | 3 | 2011 | 26 | 0.510 |
Why?
|
| Signal Transduction | 5 | 2024 | 1908 | 0.510 |
Why?
|
| Green Fluorescent Proteins | 3 | 2015 | 208 | 0.510 |
Why?
|
| Spinal Cord | 3 | 2013 | 94 | 0.500 |
Why?
|
| Neurons | 7 | 2018 | 1175 | 0.500 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2014 | 1 | 0.480 |
Why?
|
| Receptors, HIV | 1 | 2013 | 5 | 0.460 |
Why?
|
| Receptors, Cytokine | 1 | 2013 | 12 | 0.460 |
Why?
|
| Autoimmunity | 2 | 2013 | 53 | 0.460 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 628 | 0.430 |
Why?
|
| Mice, Knockout | 8 | 2021 | 933 | 0.420 |
Why?
|
| T-Lymphocytes | 4 | 2016 | 357 | 0.400 |
Why?
|
| Neurogenesis | 3 | 2018 | 58 | 0.400 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 123 | 0.400 |
Why?
|
| Embryonic Development | 1 | 2011 | 76 | 0.390 |
Why?
|
| Embryo, Mammalian | 1 | 2011 | 153 | 0.390 |
Why?
|
| Mesocestoides | 4 | 2013 | 23 | 0.390 |
Why?
|
| Malaria, Cerebral | 2 | 2023 | 31 | 0.390 |
Why?
|
| Tauopathies | 3 | 2018 | 20 | 0.380 |
Why?
|
| Cytological Techniques | 1 | 2011 | 15 | 0.380 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2002 | 88 | 0.370 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2011 | 286 | 0.350 |
Why?
|
| Nervous System Diseases | 2 | 2007 | 71 | 0.340 |
Why?
|
| Lateral Ventricles | 2 | 2021 | 8 | 0.320 |
Why?
|
| Glial Fibrillary Acidic Protein | 3 | 2024 | 70 | 0.300 |
Why?
|
| Humans | 16 | 2024 | 37093 | 0.300 |
Why?
|
| Membrane Glycoproteins | 2 | 2022 | 211 | 0.290 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2006 | 35 | 0.270 |
Why?
|
| Oligodendroglia | 2 | 2021 | 24 | 0.270 |
Why?
|
| Cells, Cultured | 7 | 2021 | 1518 | 0.260 |
Why?
|
| Stem Cell Niche | 2 | 2016 | 10 | 0.260 |
Why?
|
| Organ Specificity | 2 | 2018 | 129 | 0.250 |
Why?
|
| Diphtheria Toxin | 1 | 2024 | 4 | 0.240 |
Why?
|
| Receptors, Immunologic | 2 | 2022 | 61 | 0.240 |
Why?
|
| Vimentin | 1 | 2024 | 37 | 0.240 |
Why?
|
| tau Proteins | 3 | 2018 | 167 | 0.240 |
Why?
|
| RNA | 1 | 2006 | 241 | 0.230 |
Why?
|
| Immunologic Factors | 1 | 2024 | 45 | 0.230 |
Why?
|
| Protein Isoforms | 1 | 2024 | 130 | 0.230 |
Why?
|
| Diabetes Complications | 1 | 2024 | 90 | 0.220 |
Why?
|
| Killer Cells, Natural | 2 | 2016 | 92 | 0.220 |
Why?
|
| Gene Expression Regulation | 4 | 2018 | 1015 | 0.220 |
Why?
|
| Bone Marrow Cells | 2 | 2013 | 81 | 0.220 |
Why?
|
| Chemokines, CC | 1 | 2003 | 51 | 0.220 |
Why?
|
| Mice, Inbred BALB C | 4 | 2016 | 661 | 0.220 |
Why?
|
| Cuprizone | 1 | 2022 | 5 | 0.210 |
Why?
|
| Myelin Sheath | 1 | 2022 | 48 | 0.210 |
Why?
|
| Homeostasis | 2 | 2014 | 188 | 0.200 |
Why?
|
| Peptide Fragments | 2 | 2013 | 308 | 0.200 |
Why?
|
| Carrier Proteins | 1 | 2023 | 305 | 0.190 |
Why?
|
| Cell Movement | 6 | 2018 | 571 | 0.190 |
Why?
|
| Chemokine CCL2 | 3 | 2008 | 85 | 0.180 |
Why?
|
| Ligands | 2 | 2013 | 349 | 0.170 |
Why?
|
| Chromatin | 2 | 2018 | 169 | 0.170 |
Why?
|
| Immunohistochemistry | 3 | 2014 | 893 | 0.170 |
Why?
|
| Vasculitis, Central Nervous System | 1 | 2018 | 1 | 0.160 |
Why?
|
| Integrases | 1 | 2018 | 26 | 0.160 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 51 | 0.150 |
Why?
|
| Lymphocyte Activation | 3 | 2013 | 236 | 0.150 |
Why?
|
| Dendritic Cells | 3 | 2013 | 113 | 0.150 |
Why?
|
| Female | 8 | 2016 | 20969 | 0.140 |
Why?
|
| Histones | 2 | 2018 | 190 | 0.140 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 515 | 0.140 |
Why?
|
| Mast Cells | 1 | 2016 | 81 | 0.130 |
Why?
|
| Neuroimmunomodulation | 1 | 2015 | 13 | 0.130 |
Why?
|
| Nitrites | 1 | 2015 | 46 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2018 | 356 | 0.130 |
Why?
|
| Neutrophils | 1 | 2016 | 131 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 161 | 0.120 |
Why?
|
| Alzheimer Disease | 2 | 2013 | 905 | 0.120 |
Why?
|
| Adult Stem Cells | 1 | 2014 | 12 | 0.120 |
Why?
|
| Memory Disorders | 1 | 2015 | 73 | 0.120 |
Why?
|
| Lipopolysaccharides | 3 | 2018 | 220 | 0.120 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2013 | 12 | 0.120 |
Why?
|
| Antigens | 1 | 2013 | 56 | 0.120 |
Why?
|
| Immunity | 1 | 2014 | 53 | 0.120 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2013 | 3 | 0.120 |
Why?
|
| Antigens, Ly | 1 | 2013 | 8 | 0.120 |
Why?
|
| Chimera | 1 | 2013 | 15 | 0.110 |
Why?
|
| Lymphoid Tissue | 1 | 2013 | 18 | 0.110 |
Why?
|
| Interleukin-1 | 1 | 2013 | 35 | 0.110 |
Why?
|
| Brain Injuries | 1 | 2015 | 121 | 0.110 |
Why?
|
| Adaptive Immunity | 1 | 2013 | 27 | 0.110 |
Why?
|
| Analysis of Variance | 3 | 2015 | 550 | 0.110 |
Why?
|
| Granulocyte Precursor Cells | 1 | 2013 | 2 | 0.110 |
Why?
|
| Interleukin-17 | 1 | 2013 | 53 | 0.110 |
Why?
|
| Nitric Oxide | 1 | 2015 | 316 | 0.110 |
Why?
|
| Mannose-Binding Lectins | 1 | 2013 | 14 | 0.110 |
Why?
|
| Aging | 1 | 2018 | 664 | 0.110 |
Why?
|
| Lectins, C-Type | 1 | 2013 | 36 | 0.110 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 80 | 0.110 |
Why?
|
| Microfilament Proteins | 2 | 2018 | 69 | 0.110 |
Why?
|
| Calcium-Binding Proteins | 2 | 2018 | 76 | 0.110 |
Why?
|
| Receptors, Cell Surface | 1 | 2013 | 144 | 0.100 |
Why?
|
| Interferon-gamma | 1 | 2013 | 250 | 0.100 |
Why?
|
| Macrophage Activation | 2 | 2015 | 56 | 0.100 |
Why?
|
| Cell Cycle | 1 | 2013 | 326 | 0.100 |
Why?
|
| Blood-Brain Barrier | 3 | 2008 | 162 | 0.100 |
Why?
|
| Genes, T-Cell Receptor delta | 2 | 2002 | 5 | 0.100 |
Why?
|
| Lymphocyte Subsets | 1 | 2011 | 21 | 0.100 |
Why?
|
| Phagocytes | 1 | 2010 | 6 | 0.100 |
Why?
|
| Maze Learning | 3 | 2018 | 105 | 0.090 |
Why?
|
| Th1 Cells | 2 | 2002 | 92 | 0.090 |
Why?
|
| Cell Proliferation | 2 | 2013 | 1198 | 0.090 |
Why?
|
| Cell Lineage | 1 | 2010 | 90 | 0.090 |
Why?
|
| Gene Expression | 2 | 2021 | 674 | 0.090 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2010 | 95 | 0.090 |
Why?
|
| Microscopy, Confocal | 3 | 2021 | 218 | 0.090 |
Why?
|
| Stem Cells | 1 | 2010 | 141 | 0.090 |
Why?
|
| Male | 5 | 2015 | 20025 | 0.090 |
Why?
|
| Adoptive Transfer | 2 | 2013 | 48 | 0.080 |
Why?
|
| Chemokine CXCL2 | 1 | 2008 | 11 | 0.080 |
Why?
|
| Chemokine CXCL1 | 1 | 2008 | 15 | 0.080 |
Why?
|
| Chemokine CXCL10 | 1 | 2008 | 37 | 0.080 |
Why?
|
| Brain Chemistry | 1 | 2008 | 140 | 0.080 |
Why?
|
| Neuritis, Autoimmune, Experimental | 1 | 2007 | 1 | 0.070 |
Why?
|
| Chemokines, CX3C | 1 | 2007 | 1 | 0.070 |
Why?
|
| Chemotactic Factors | 1 | 2007 | 7 | 0.070 |
Why?
|
| Nervous System | 1 | 2007 | 29 | 0.070 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2006 | 22 | 0.070 |
Why?
|
| Motor Neuron Disease | 1 | 2006 | 4 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2021 | 587 | 0.070 |
Why?
|
| Autoimmune Diseases | 1 | 2006 | 57 | 0.070 |
Why?
|
| Severity of Illness Index | 2 | 2013 | 610 | 0.070 |
Why?
|
| Cell Death | 1 | 2006 | 267 | 0.060 |
Why?
|
| Monocytes | 1 | 2007 | 257 | 0.060 |
Why?
|
| Parkinson Disease | 1 | 2006 | 178 | 0.060 |
Why?
|
| Fibrin | 1 | 2023 | 10 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2006 | 360 | 0.060 |
Why?
|
| Chemokine CCL3 | 1 | 2003 | 14 | 0.060 |
Why?
|
| Chemokine CCL4 | 1 | 2003 | 19 | 0.060 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 2003 | 16 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2007 | 517 | 0.050 |
Why?
|
| Leukopenia | 1 | 2002 | 9 | 0.050 |
Why?
|
| Leishmaniasis, Visceral | 1 | 2001 | 7 | 0.050 |
Why?
|
| Leishmania donovani | 1 | 2001 | 17 | 0.050 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2021 | 10 | 0.050 |
Why?
|
| Spleen | 1 | 2001 | 199 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2002 | 435 | 0.050 |
Why?
|
| Phosphorylation | 2 | 2015 | 928 | 0.040 |
Why?
|
| Genes, T-Cell Receptor gamma | 1 | 1999 | 3 | 0.040 |
Why?
|
| Lymphocyte Count | 1 | 1999 | 46 | 0.040 |
Why?
|
| Antigens, Differentiation | 1 | 2018 | 25 | 0.040 |
Why?
|
| Plasmodium chabaudi | 1 | 2018 | 1 | 0.040 |
Why?
|
| Ammonia | 1 | 2018 | 17 | 0.040 |
Why?
|
| Time Factors | 2 | 2015 | 1742 | 0.040 |
Why?
|
| Heparin | 1 | 2018 | 35 | 0.040 |
Why?
|
| Larva | 1 | 1999 | 124 | 0.040 |
Why?
|
| Blood Vessels | 1 | 2018 | 34 | 0.040 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2018 | 28 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 2018 | 75 | 0.040 |
Why?
|
| Antibodies | 1 | 2018 | 141 | 0.040 |
Why?
|
| S Phase | 1 | 2018 | 37 | 0.040 |
Why?
|
| Methylation | 1 | 2018 | 113 | 0.040 |
Why?
|
| Lysine | 1 | 2018 | 113 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2018 | 102 | 0.040 |
Why?
|
| Cognition Disorders | 1 | 2018 | 233 | 0.030 |
Why?
|
| Psychomotor Disorders | 1 | 2015 | 8 | 0.030 |
Why?
|
| Rotarod Performance Test | 1 | 2015 | 14 | 0.030 |
Why?
|
| Fluoresceins | 1 | 2015 | 27 | 0.030 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2015 | 14 | 0.030 |
Why?
|
| Exploratory Behavior | 1 | 2015 | 75 | 0.030 |
Why?
|
| Liver | 1 | 2018 | 479 | 0.030 |
Why?
|
| Papio anubis | 1 | 2014 | 5 | 0.030 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2013 | 9 | 0.030 |
Why?
|
| Freund's Adjuvant | 1 | 2013 | 14 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2013 | 33 | 0.030 |
Why?
|
| Temporal Lobe | 1 | 2013 | 21 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 1 | 2013 | 60 | 0.030 |
Why?
|
| Pertussis Toxin | 1 | 2013 | 27 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2014 | 142 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2013 | 116 | 0.030 |
Why?
|
| Frontal Lobe | 1 | 2013 | 48 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 172 | 0.030 |
Why?
|
| Mutation | 1 | 2018 | 1095 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2013 | 54 | 0.030 |
Why?
|
| Immunization | 1 | 2013 | 92 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 84 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2013 | 103 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2014 | 219 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2013 | 325 | 0.030 |
Why?
|
| Hippocampus | 1 | 2015 | 561 | 0.020 |
Why?
|
| Silver Staining | 1 | 2010 | 7 | 0.020 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2010 | 8 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2010 | 46 | 0.020 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2010 | 21 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 108 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2010 | 77 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2010 | 101 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 95 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2010 | 69 | 0.020 |
Why?
|
| Cell Count | 1 | 2010 | 135 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2010 | 62 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2010 | 121 | 0.020 |
Why?
|
| Imidazoles | 1 | 2010 | 126 | 0.020 |
Why?
|
| Pyridines | 1 | 2010 | 116 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2010 | 343 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 623 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 433 | 0.020 |
Why?
|
| Phenotype | 1 | 2011 | 689 | 0.020 |
Why?
|
| Models, Biological | 1 | 2010 | 677 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2005 | 7 | 0.020 |
Why?
|
| Myelin Proteins | 1 | 2005 | 26 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2005 | 48 | 0.020 |
Why?
|
| Neurofilament Proteins | 1 | 2005 | 29 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2005 | 237 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2005 | 290 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2005 | 515 | 0.010 |
Why?
|
| Mesocricetus | 1 | 2001 | 54 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 2001 | 70 | 0.010 |
Why?
|
| Cricetinae | 1 | 2001 | 238 | 0.010 |
Why?
|
| Macrophages | 1 | 2001 | 439 | 0.010 |
Why?
|